PURPOSE: To assess the uptake of 2-[fluorine-18]-fluoro-2-deoxy-D-gluc
ose (FDG) in common and uncommon tumors in children and to develop a m
ethod for performing positron emission tomography (PET) studies in chi
ldren with malignant neoplasms. MATERIALS AND METHODS: Twenty-two pedi
atric patients with known or suspected malignancies (27 scans) underwe
nt FDG PET. Tumor uptake of FDG was measured on PET scans. RESULTS: Tu
mor uptake of FDG was detected in 17 of 21 patients with malignant dis
ease. Neuroblastomas and their metastases (including those that did no
t absorb metaiodobenzylguanidine) intensely accumulated FDG. In a pati
ent with Ewing sarcoma, FDG PET showed two foci of metastatic disease
not evident on bone scans. In two patients, PET showed that large area
s of the tumor were necrotic.CONCLUSION: FDG FET is feasible, is usefu
l in the study of tumors in children, and may provide unique, clinical
ly important information.